In line with the speculation, a loss-of-function mutation in AXIN occurs at a frequency of 3–16% in HCC, which is the second most common mutation in HCC that leads to activation of the Wnt/β-catenin signaling pathway [124,146,150]. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.